CMRF-35-Like Molecule-1, a Novel Mouse Myeloid Receptor, Can Inhibit Osteoclast Formation
Authors:
Open Access
- 15 December 2003
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 171 (12) , 6541-6548
Abstract
By homology to triggering receptor expressed by myeloid cells-2, we screened the mouse expressed sequence tag database and isolated a new single Ig domain receptor, which we have expressed and characterized. The receptor is most similar in sequence to the human CMRF-35 receptor, and thus we have named it CMRF-35-like molecule (CLM)-1. By screening the mouse genome, we determined that CLM-1 was part of a multigene family located on a small segment of mouse chromosome 11. Each contains a single Ig domain, and they are expressed mainly in cells of the myeloid lineage. CLM-1 contains multiple cytoplasmic tyrosine residues, including two that lie in consensus immunoreceptor tyrosine-based inhibitory motifs, and we demonstrate that CLM-1 can associate with Src-homology 2 containing phosphatase-1. Expression of CLM-1 mRNA is down-regulated by treatment with receptor activator of NF-κB ligand (RANKL), a cytokine that drives osteoclast formation. Furthermore, expression of CLM-1 in the osteoclastogenic cell line RAW (RAW.CLM-1) prevents osteoclastogenesis induced by RANKL and TGF-β. RAW.CLM-1 cells fail to multinucleate and do not up-regulate calcitonin receptor, but they express tartrate-resistant acid phosphatase, cathepsin K, and β3 integrin, suggesting that osteoclastogenesis is blocked at a late-intermediate stage. Thus, we define a new family of myeloid receptors, and demonstrate that the first member of this family, CLM-1, is an inhibitory receptor, able to block osteoclastogenesis.Keywords
This publication has 39 references indexed in Scilit:
- Characterization of a Murine NKT Cell Tumor Previously Described as an Acute Myelogenous LeukemiaLeukemia & Lymphoma, 2002
- Regulation of the Natural Killer Cell Receptor RepertoireAnnual Review of Immunology, 2001
- Cloning and characterization of a novel mouse myeloid DAP12-associated receptor familyEuropean Journal of Immunology, 2001
- Bone Resorption by OsteoclastsScience, 2000
- The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me/me mutant miceBone, 1999
- Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand FamiliesEndocrine Reviews, 1999
- CD44 Occupancy Prevents Macrophage MultinucleationJournal of Cell Biology, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitoninEndocrinology, 1995
- Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells.Journal of Experimental Medicine, 1991